Long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery

Ji Won Jung, Kye Yoon Kwon, Deana Lynn Choi, Tae-im Kim, Eungkweon Kim, KyoungYul Seo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: The aim of this study was to investigate long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery. Methods: We examined 73 surgical sites (nasal and/or temporal area) in 60 eyes from 43 patients who underwent conjunctival flap surgery for calcified scleromalacia arising from cosmetic wide conjunctivectomy or pterygium excision. Clinical outcomes, including the need for reoperation and development of complications, were evaluated over a long-term follow-up period. Morphological evaluations of the surgical area at final follow-up were performed using a total score for injection severity, ocular surface smoothness, and choroid visibility, and patients subjectively evaluated their cosmetic outcome using a scale of 0 (very poor) to 4 (excellent). Results: The mean follow-up duration after final conjunctival flap surgery was 26.5 ± 6.8 months (range, 15-52 months). There were no cases of progressive scleral thinning or serious complications such as flap necrosis or scleral perforation. Only 3 surgical areas with an inferior flap required additional flap placement because of avascular sclera exposure. Minor complications such as conjunctival cyst, edematous flap, vessel engorgement, and flap hypertrophy were easily treated or spontaneously improved. Mean morphological score was 2.2 and cosmetic outcome score was 2.9, indicating almost "good" outcomes. Conclusions: Based on our long-term experience, we propose that conjunctival flap surgery may be a safe and satisfactory treatment for complicated calcified scleromalacia after periocular surgery.

Original languageEnglish
Pages (from-to)308-312
Number of pages5
JournalCornea
Volume34
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Cosmetics
Pterygium
Sclera
Choroid
Reoperation
Nose
Hypertrophy
Cysts
Necrosis
Injections
Therapeutics

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

@article{c38594b2d56244edabbc1fb12568e321,
title = "Long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery",
abstract = "Purpose: The aim of this study was to investigate long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery. Methods: We examined 73 surgical sites (nasal and/or temporal area) in 60 eyes from 43 patients who underwent conjunctival flap surgery for calcified scleromalacia arising from cosmetic wide conjunctivectomy or pterygium excision. Clinical outcomes, including the need for reoperation and development of complications, were evaluated over a long-term follow-up period. Morphological evaluations of the surgical area at final follow-up were performed using a total score for injection severity, ocular surface smoothness, and choroid visibility, and patients subjectively evaluated their cosmetic outcome using a scale of 0 (very poor) to 4 (excellent). Results: The mean follow-up duration after final conjunctival flap surgery was 26.5 ± 6.8 months (range, 15-52 months). There were no cases of progressive scleral thinning or serious complications such as flap necrosis or scleral perforation. Only 3 surgical areas with an inferior flap required additional flap placement because of avascular sclera exposure. Minor complications such as conjunctival cyst, edematous flap, vessel engorgement, and flap hypertrophy were easily treated or spontaneously improved. Mean morphological score was 2.2 and cosmetic outcome score was 2.9, indicating almost {"}good{"} outcomes. Conclusions: Based on our long-term experience, we propose that conjunctival flap surgery may be a safe and satisfactory treatment for complicated calcified scleromalacia after periocular surgery.",
author = "Jung, {Ji Won} and Kwon, {Kye Yoon} and Choi, {Deana Lynn} and Tae-im Kim and Eungkweon Kim and KyoungYul Seo",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/ICO.0000000000000326",
language = "English",
volume = "34",
pages = "308--312",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery. / Jung, Ji Won; Kwon, Kye Yoon; Choi, Deana Lynn; Kim, Tae-im; Kim, Eungkweon; Seo, KyoungYul.

In: Cornea, Vol. 34, No. 3, 01.01.2015, p. 308-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery

AU - Jung, Ji Won

AU - Kwon, Kye Yoon

AU - Choi, Deana Lynn

AU - Kim, Tae-im

AU - Kim, Eungkweon

AU - Seo, KyoungYul

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: The aim of this study was to investigate long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery. Methods: We examined 73 surgical sites (nasal and/or temporal area) in 60 eyes from 43 patients who underwent conjunctival flap surgery for calcified scleromalacia arising from cosmetic wide conjunctivectomy or pterygium excision. Clinical outcomes, including the need for reoperation and development of complications, were evaluated over a long-term follow-up period. Morphological evaluations of the surgical area at final follow-up were performed using a total score for injection severity, ocular surface smoothness, and choroid visibility, and patients subjectively evaluated their cosmetic outcome using a scale of 0 (very poor) to 4 (excellent). Results: The mean follow-up duration after final conjunctival flap surgery was 26.5 ± 6.8 months (range, 15-52 months). There were no cases of progressive scleral thinning or serious complications such as flap necrosis or scleral perforation. Only 3 surgical areas with an inferior flap required additional flap placement because of avascular sclera exposure. Minor complications such as conjunctival cyst, edematous flap, vessel engorgement, and flap hypertrophy were easily treated or spontaneously improved. Mean morphological score was 2.2 and cosmetic outcome score was 2.9, indicating almost "good" outcomes. Conclusions: Based on our long-term experience, we propose that conjunctival flap surgery may be a safe and satisfactory treatment for complicated calcified scleromalacia after periocular surgery.

AB - Purpose: The aim of this study was to investigate long-term clinical outcomes of conjunctival flap surgery for calcified scleromalacia after periocular surgery. Methods: We examined 73 surgical sites (nasal and/or temporal area) in 60 eyes from 43 patients who underwent conjunctival flap surgery for calcified scleromalacia arising from cosmetic wide conjunctivectomy or pterygium excision. Clinical outcomes, including the need for reoperation and development of complications, were evaluated over a long-term follow-up period. Morphological evaluations of the surgical area at final follow-up were performed using a total score for injection severity, ocular surface smoothness, and choroid visibility, and patients subjectively evaluated their cosmetic outcome using a scale of 0 (very poor) to 4 (excellent). Results: The mean follow-up duration after final conjunctival flap surgery was 26.5 ± 6.8 months (range, 15-52 months). There were no cases of progressive scleral thinning or serious complications such as flap necrosis or scleral perforation. Only 3 surgical areas with an inferior flap required additional flap placement because of avascular sclera exposure. Minor complications such as conjunctival cyst, edematous flap, vessel engorgement, and flap hypertrophy were easily treated or spontaneously improved. Mean morphological score was 2.2 and cosmetic outcome score was 2.9, indicating almost "good" outcomes. Conclusions: Based on our long-term experience, we propose that conjunctival flap surgery may be a safe and satisfactory treatment for complicated calcified scleromalacia after periocular surgery.

UR - http://www.scopus.com/inward/record.url?scp=84923560793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923560793&partnerID=8YFLogxK

U2 - 10.1097/ICO.0000000000000326

DO - 10.1097/ICO.0000000000000326

M3 - Article

VL - 34

SP - 308

EP - 312

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 3

ER -